Variations of p53 in cultured fibroblasts of patients with lung cancer who have a presumed genetic predisposition

被引:6
作者
Auer, H
Warncke, K
Nowak, D
Koops, F
Jaeger, U
Kurzbauer, R
Ruediger, HW
机构
[1] Univ Vienna, Dept Occupat Med, A-1090 Vienna, Austria
[2] Univ Munich, Inst Occupat & Environm Med, Munich, Germany
[3] Univ Hamburg, Inst Occupat Med, Hamburg, Germany
[4] Univ Vienna, Dept Hematol, Vienna, Austria
[5] Res Inst Mol Pathol, A-1030 Vienna, Austria
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1999年 / 22卷 / 03期
关键词
lung cancer genetics; p53 tumor suppressor gene; Li-Fraumeni syndrome;
D O I
10.1097/00000421-199906000-00013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The authors studied cultured skin fibroblasts of 64 patients with lung cancer for constitutive mutations of the p53 tumor suppressor gene by using polymerase chain reaction and single-strand conformation polymorphism covering the entire coding region. The patients were considered to be genetically predisposed because lung cancer had developed in 25 of them before age 46 and because 42 of them had at least one first-degree relative with lung cancer. One mutation was detected at position 235 coding for serine instead of asparagine in the conserved DNA binding domain. The Pro/Pro genotype at codon 72 of p53, considered to harbor an increased risk for lung cancer, could not be detected with increased frequency in this study's patients. From these data, the authors conclude that constitutive variations of the p53 gene do not represent a major genetic determinant for lung cancer.
引用
收藏
页码:278 / 282
页数:5
相关论文
共 46 条
[1]  
AHUJA HG, 1990, ONCOGENE, V5, P1409
[2]   IS P53 POLYMORPHISM MAINTAINED BY NATURAL-SELECTION [J].
BECKMAN, G ;
BIRGANDER, R ;
SJALANDER, A ;
SAHA, N ;
HOLMBERG, PA ;
KIVELA, A ;
BECKMAN, L .
HUMAN HEREDITY, 1994, 44 (05) :266-270
[3]   P53 POLYMORPHISMS AND HAPLOTYPES IN LUNG-CANCER [J].
BIRGANDER, R ;
SJALANDER, A ;
RANNUG, A ;
ALEXANDRIE, AK ;
SUNDBERG, MI ;
SEIDEGARD, J ;
TORNLING, G ;
BECKMAN, G ;
BECKMAN, L .
CARCINOGENESIS, 1995, 16 (09) :2233-2236
[4]  
BOSCO EF, 1993, AM J HUM GENET, V53, P752
[5]  
CARBONE D, 1991, ONCOGENE, V6, P1691
[6]  
CHIBA I, 1990, ONCOGENE, V5, P1603
[7]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[8]  
DAGOSTINI F, 1995, CANCER EPIDEM BIOMAR, V4, P111
[9]   Molecular mechanisms of lung cancer - Interaction of environmental and genetic factors [J].
Devereux, TR ;
Taylor, JA ;
Barrett, JC .
CHEST, 1996, 109 (03) :S14-S19
[10]  
FELIX CA, 1994, ONCOGENE, V9, P327